Broadwind Energy Completes Acquisition of Red Wolf

Broadwind Energy Completes Acquisition of Red Wolf

Broadwind Energy said pre-market Wednesday it completed the acquisition of Red Wolf Company, a privately held fabricator, kitter and assembler of industrial systems in the global gas turbine market. Details of the takeover price undisclosed. For external reporting purposes, Red Wolf’s financials will be combined with Broadwind’s nascent entry into the CNG compression systems business, which is currently operated out of Abilene, Texas. The new business segment, Broadwind Process Systems, […]

Read More ˃
Columbus McKinnon Completes Acquisition of STAHL CraneSystems

Columbus McKinnon Completes Acquisition of STAHL CraneSystems

Columbus McKinnon said pre-market Tuesday that it completed its acquisition of STAHL CraneSystems.Columbus McKinnon acquired all of the issued and outstanding capital stock of the STAHL CraneSystems business for an all-cash purchase price of EUR224 million ($240 million) net of cash and debt acquired from Konecranes Plc. Columbus McKinnon expects the cost synergies before purchase accounting and charges to contribute $0.34 per share of earnings accretion during fiscal 2018 and […]

Read More ˃
Ennis Acquires Independent Printing Company and Related Entities

Ennis Acquires Independent Printing Company and Related Entities

Ennis, a company engaged in the production and sale of business forms, other business products and apparel to customers, said Monday that it has acquired Independent Printing Company, Inc. and related entities in a stock purchase transaction that closed Jan. 27, for an undisclosed amount. Independent had sales of approximately $37 million for the calendar year just ended and sells mainly through distributors and resellers, Ennis said. The majority stockholder […]

Read More ˃
Biogen and Mitsubishi Tanabe Terminate Licensing Accord

Biogen and Mitsubishi Tanabe Terminate Licensing Accord

Biogen and Mitsubishi Pharma Corp. have agreed to terminate a licence accord on MT-1303, a therapeutic agent for autoimmune diseases. Under the termination, Mitsubishi regains all development and marketing rights in the world for all indications of MT-1303 and will record a lump sum revenue, booked as liability of deferred income at the end of December 2016 based on IFRS in the 4th quarter, FY2016. The license accord dated from […]

Read More ˃
Endologix Reports Positive Three-Year Results

Endologix Reports Positive Three-Year Results

Endologix, which is developing treatments for aortic disorders, presented positive three-year results from the Ovation European post-market registry data at a conference in Leipzig, Germany. Through three years of follow-up, key study results included 99% freedom from aneurysm-related mortality, 99% freedom from migration, rupture, and conversion, the company said on Wednesday. “The addition of these European results continue to validate the excellent clinical results and durability of the ultra-low profile […]

Read More ˃